BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 17, 2026

  March 18, 2026

   · 

  1 min read
• Press Releases

  AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights

  March 18, 2026

   · 

  13 min read
• Press Releases

  Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

  March 18, 2026

   · 

  13 min read
• Press Releases

  ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting

  March 18, 2026

   · 

  7 min read
• Press Releases

  Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  March 18, 2026

   · 

  12 min read
• Press Releases

  Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

  March 18, 2026

   · 

  6 min read
• Press Releases

  ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

  March 18, 2026

   · 

  7 min read
• Press Releases

  Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

  March 18, 2026

   · 

  5 min read
• Press Releases

  Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - March 17, 2026

  March 18, 2026

   · 

  1 min read
• Press Releases

  Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026

  March 18, 2026

   · 

  2 min read